- Bepanthen*, the top skincare brand in the world, makes its debut in India to address the country’s pervasive dry skin issues.
- According to dermatologists, about one in two consumers in the general public have dry skin.
- According to 82% of dermatologists polled, patients are afraid of their skin being revealed when they go out in public.
- The necessity for specialist skincare treatments is highlighted by the fact that 88% of dermatologists attribute skin flare-ups to environmental causes.
November 2024 in Hyderabad — The world’s top skincare brand, Bepanthen, is proudly being introduced to the Indian market by Bayer’s Consumer Health Division. Additionally, an Ipsos** poll of Indian dermatologists highlights the prevalence of dry skin in the general population. According to 82% of dermatologists, patients frequently dismiss recurring dry skin as “just dry skin” without realizing that there may be a more serious underlying skin disease.
Insightful accounts of the prevalence of dry skin conditions in our nation are provided by the 2024 Bepanthen Survey on Dry Skin, which was carried out in seven cities. The results highlight the urgent need to address skincare concerns faced by people with dry, irritated, and sensitive skin. With 75 years of experience and efficacy, Bepanthen strives to offer unparalleled comfort for skin that is sensitive and dry.
Nine out of ten dermatologists who participated in the Bepanthen Dry Skin Survey concurred that adult patients currently lack adequate understanding about recurrent dry skin diseases and how to treat them. Nearly one in three people with dry skin who consult a dermatologist experience recurrent dryness. According to dermatologists, people with dry skin typically use over-the-counter moisturizers and home cures before seeing a specialist.
Bayer Consumer Health responded to these findings by launching Bepanthen, the #1 skincare brand in the world, in India. Bepanthen provides a specific line of body and face cleansers and moisturizers made to cater to the particular requirements of Indian skin. In addition to offering instant relief for dry, irritated, and sensitive skin, Bepanthen’s fragrance-free, paraben-free solution, enhanced with pro-vitamin B5 and prebiotics, promotes long-term skin health and skin regeneration. Bepanthen is committed to helping people attain healthier skin and bridging the information gap regarding dry skin diseases by filling in the important gaps found in the study.
“What is interesting to note in the 2024 Bepanthen Survey on Dry Skin is that sometimes people cannot distinguish between just dry skin and chronic dry skin, even though some of them look up more information online,” said Sandeep Verma, Country Head for India, Bangladesh, and Sri Lanka at Bayer’s Consumer Health Division. At Bayer, we want to close this information gap and assist individuals know when and how to get help. Bepanthen products are made to improve the quality of life for people who frequently neglect the health of their skin; they do more than merely moisturize. Bepanthen’s foray into India is a major advancement in our goal of offering high-end skincare products supported by science.
“The clinical efficacy of the Bepanthen range in managing dermatitis and eczema is highly significant,” continued Dr. Ratnapal Shah, Senior Dermatologist, MBBS DVD. For general skin health, these problems must be effectively addressed. The need of taking care of dry and itchy skin is often overlooked by patients, which exacerbates these disorders. Long-term skin wellness can be maintained and flare-ups can be minimized by knowing how to protect and soothe the skin.
Bepanthen is known throughout the world for its innovative medicated moisturizers, which have been clinically shown to be just as effective as 1% hydrocortisone for skin prone to dermatitis and atopic eczema. According to 86% of dermatologists, a complete therapy for sensitive skin can be obtained by mixing medicated moisturizers with face and body cleansers.
Bepanthen, a holistic skincare line for dry skin management, was introduced in India and boasts 75 years of worldwide experience supported by 11 clinical studies. Its pure formulas, devoid of colorants, fragrances, and parabens, have received dermatological approval. After that, Bepanthen begins working on the first application. There are four items in the line, each with a different pro-vitamin B5 and prebiotic combination. It is a steroid-free solution for eczema-prone skin and contains a daily moisturizing cream, mild body and face cleansers, and an itching relief cream that restores excessively dry skin. Steroid-free formulations are preferred by 80% of dermatologists. The top skincare authority in the world, Bepanthen, is dedicated to easing sensitive, dry, and irritated skin.
Important observations made by dermatologists who participated in the Bepanthen Dry Skin Survey:
- Dermatologists estimate that nearly one in two Indians, or 47% on average, have dry skin.
- Thirty percent of persons who see a dermatologist have problems relating to dry skin.
- Nearly one in three (32%) people with dry skin who see a dermatologist have dry, itchy, or sensitive skin on a regular basis.
- According to 82% of dermatologists, patients are afraid of their skin being revealed when they go out in public.
- According to more than half of dermatologists, patients who have ongoing physical discomfort often become more irritable.
- According to 93% of dermatologists, adult patients with recurrent dry, irritated, or sensitive skin diseases now lack knowledge about how to properly manage their conditions.
- 88% of dermatologists believe that environmental variables, such as dry and cold weather, are to blame for flare-ups.
- According to 80% of dermatologists, up to 30% of recurring patients have the problem all year long.
- According to 75% of dermatologists, those between the ages of 25 and 40 are most likely to experience dry, itchy, and sensitive skin on a regular basis.
- Eighty percent of dermatologists concur that they will recommend a medicated moisturizer without cortisone.
- According to dermatologists, around one in two Indians, or 47% of the general population, suffer from dry skin.
- Among people with dry skin, the average prevalence of recurrent dry, irritated, or sensitive skin is 34% (1 in 3).
- The average prevalence of all-year incidence among people who frequently suffer from dry, irritated, or sensitive skin: 21%
- 25 to 40 years old is the age group most likely to experience recurrent dry, itchy, and sensitive skin.
- On average, one out of three patients (29.5%) who see a dermatologist suffer from issues connected to dry skin.
Here are some more findings and data from dermatologists polled for the “Bepanthen Dry Skin Survey.”
| Gen pop:· · According to dermatologists, around one in two Indians, or 47% of the general population, suffer from dry skin. · Among people with dry skin, the average prevalence of recurrent dry, irritated, or sensitive skin is 34% (1 in 3). · The average prevalence of all-year incidence among people who frequently suffer from dry, irritated, or sensitive skin: 21% · 25 to 40 years old is the age group most likely to experience recurrent dry, itchy, and sensitive skin. · On average, one out of three patients (29.5%) who see a dermatologist suffer from issues connected to dry skin. · Among those with dry skin who are seeing dermatologists: i. Patients with recurring dry, irritated, or sensitive skin make up 32% (around 1 in 3). ii. Nearly all people with recurring dry, irritated, or sensitive skin experience year-round suffering. Delay in visiting dermat: · Forty percent of patients do not see a dermatologist until over a month following the onset of symptoms. · A third of adult patients with recurring dry, irritated, or sensitive skin disorders (such as dermatitis or eczema) first see a dermatologist for other skin conditions before receiving a diagnosis of recurrent dry, irritated, or sensitive skin conditions. · On their first visit to the doctor, 36% (1 in 3) of adult patients with recurrent dry, itchy, or sensitive skin disorders (such as dermatitis or eczema) may exhibit moderate to severe symptoms. Low seriousness regarding the condition: · Eighty-two percent of dermatologists concur that patients often dismiss recurrent dry, irritated, or sensitive skin as “just dry skin” without realizing that there may be an underlying skin issue, such as dermatitis or eczema. · Eighty percent of dermatologists concur that people with dry skin disorders don’t take their conditions seriously enough to think about seeing a dermatologist. Most visible body areas given more importance: · According to 61% of dermatologists, when they see patients with recurrent dry, irritated, or sensitive skin disorders, the most affected body areas are the face or visible portions of the arms, primarily the hands and forearms. Use of inappropriate solutions before dermat visit: · According to 89% of dermatologists, individuals with recurrent dry, itchy, or sensitive skin diseases (such dermatitis or eczema) may attempt home remedies as soon as symptoms appear before seeing a doctor. · Adults with recurrent dry, itchy, or sensitive skin disorders (such as dermatitis or eczema) may use general moisturizers when symptoms begin to appear before seeing a dermatologist, according to three out of four (75%) dermatologists. Dermats’ high preference for non-steroid medication: · Emollients, or medicated moisturizers, were regarded by 88% of dermatologists as one of the top 3 often prescribed therapies for adult patients with recurrent dry, irritated, or sensitive skin diseases (such as dermatitis or eczema). For adult patients with recurring dry, irritated, or sensitive skin disorders (such as dermatitis or eczema), approximately one in two (54%) physicians selected EMOLLIENTS as the most commonly prescribed treatment. · For skin prone to atopic dermatitis or eczema, 80% of dermatologists concur that they will prescribe a medicated moisturizer without cortisone, which has been clinically shown to be just as effective as 1% hydrocortisone. Low adherence to treatment among patients: · About one in three (32%) adult patients treated for recurring dry, irritated, or sensitive skin disorders (such as dermatitis or eczema) may have moderate to low adherence to treatment strategies, according to dermatologists. · Concerns about steroid side effects were listed by 48% of dermatologists as one of the top 3 reasons why patients don’t follow their treatment programs. Regimen approach is the solution to improve adherence: · According to 86% of dermatologists, patients with recurrent dry, irritated, or sensitive skin problems (such as dermatitis or eczema) can benefit from using medicated moisturizers both during and after treatment to prevent flare-ups, as well as medicated body wash and face wash. High impact on quality of life: · According to 84% of dermatologists, patients prefer to worry less about their condition until their dry, itchy, sensitive skin or flare-ups can be covered up with clothing. · According to 82% of dermatologists, patients are afraid of their skin being revealed when they go out in public. Knowledge gap exists: · According to 45% of dermatologists, the most prevalent behavior among adult patients with recurrent dry, itchy, or sensitive skin disorders is researching the symptoms online and taking drugs or remedies based on recommendations from the internet before visiting a doctor. · According to nine out of ten (93%) dermatologists, adult patients with recurrent dry, irritated, or sensitive skin disorders (such as dermatitis or eczema) now lack adequate understanding about their illness and how to treat it. Triggers: · According to 88% of dermatologists, individuals may experience abrupt flare-ups of recurrent dry, itchy, or sensitive skin disorders (such as dermatitis or eczema) due to environmental variables like cold, dry weather. · 85%: Contact with irritating substances such as harsh cleansers, smoke, air pollution, or textiles like wool and synthetic fibers |
Glossary*- Nicholas Halls global CHC database, DB6 MAT Q4 2022. Non-prescription. Medicated.
**With a total sample size of 208 dermatologists, Ipsos Research Private Limited conducted research in 7 Indian cities.
